Which NSAID to choose for treatment of pain syndrome in polymorbid patients?
- 18 December 2021
- journal article
- research article
- Published by Alfmed LLC in Medical alphabet
- No. 35,p. 41-46
Abstract
A polymorbid patient is a patient with several diseases occurring simultaneously at different stages and phases of their development. Patients with polymorbid pathology have a statistically significant almost 2.5 times higher risk (odds ratio [OR] = 2.41; p = 0.01) of pain syndrome and other diseases (for example, depression, arterial hypertension, etc.), which will contribute to the progression of polymorbidity. Individuals with chronic pain have a significantly increased risk of all causes’ death (hazard ratio [HR] = 1.95; 95 % confidence interval [CI]: 1.26–3.03) and cardiovascular causes (RR = 2.72; 95 % CI: 1.41–5.26) compared to patients without chronic pain. Therefore, in order to improve the prognosis and quality of life of the patient, both acute and chronic pain must be treated with non-pharmacological (exercise therapy, taping, virtual reality, etc.) and pharmacological methods. Non-steroidal anti-inflammatory drugs (NSAIDs) are the first-line treatment for mild to moderate pain. The rational choice of NSAIDs in polymorbid patients can be difficult due to the presence of pathologies that limit their use or conditions that are risk factors of complications of drug therapy. In this article, the author present approaches to choosing the optimal NSAID in polymorbid patients, and justify efficacy and safety of administration of original meloxicam in these individuals (Movalis®, Boehringer Ingelheim International).Keywords
This publication has 31 references indexed in Scilit:
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform MethodologyThe Annals of Family Medicine, 2012
- Risk factors for acute kidney injury by non-steroidal anti-inflammatory drugs in patients with hyperuricaemiaRheumatology, 2011
- Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002–2006Fundamental & Clinical Pharmacology, 2011
- Aging with multimorbidity: A systematic review of the literatureAgeing Research Reviews, 2011
- Increased mortality among individuals with chronic widespread pain relates to lifestyle factors: A prospective population-based studyDisability and Rehabilitation, 2009
- More data on major depression as an antecedent risk factor for first onset of chronic back painPsychological Medicine, 2005
- Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjectsJACC, 2005
- A Long-Term Study to Evaluate the Safety and Efficacy of Meloxicam Therapy in Patients with Rheumatoid ArthritisRheumatology, 1996
- Non Steroidal Anti Inflammatory Drugs-An OverviewJournal of Medicine, 1970